Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$70.23
-0.4%
$67.13
$58.89
$89.83
$13.75B0.842.48 million shs2.05 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$84.53
-0.3%
$80.72
$61.94
$89.34
$9.66B0.811.28 million shs1.02 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$539.36
-1.0%
$555.96
$518.55
$769.98
$42.99B1.55656,641 shs459,353 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$73.11
$67.93
$59.74
$94.75
$4.36B0.52765,526 shs444,784 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-0.38%-3.93%+6.17%+9.02%-4.29%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
-0.47%-4.23%+5.53%+9.01%+13.94%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-1.03%-6.37%-0.36%-4.69%-0.24%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.00%-3.23%+8.68%+6.61%-14.05%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$70.23
-0.4%
$67.13
$58.89
$89.83
$13.75B0.842.48 million shs2.05 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$84.53
-0.3%
$80.72
$61.94
$89.34
$9.66B0.811.28 million shs1.02 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$539.36
-1.0%
$555.96
$518.55
$769.98
$42.99B1.55656,641 shs459,353 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$73.11
$67.93
$59.74
$94.75
$4.36B0.52765,526 shs444,784 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-0.38%-3.93%+6.17%+9.02%-4.29%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
-0.47%-4.23%+5.53%+9.01%+13.94%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-1.03%-6.37%-0.36%-4.69%-0.24%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.00%-3.23%+8.68%+6.61%-14.05%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
2.38
Hold$81.8516.54% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.40
Hold$87.643.68% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.60
Moderate Buy$751.0039.24% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.64
Moderate Buy$92.8026.93% Upside

Current Analyst Ratings Breakdown

Latest HSIC, COO, IDXX, and MMSI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/14/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
DowngradeHold (C+)Hold (C)
7/10/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Reiterated RatingOverweight
7/8/2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Initiated CoverageMarket Perform$85.00
7/8/2026
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Reiterated RatingNeutral$69.00 ➝ $76.00
7/8/2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
UpgradeHold
6/25/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
UpgradeHold (C)Hold (C+)
6/11/2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
UpgradeNeutralBuy$100.00
6/8/2026
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
DowngradeHold (C-)Sell (D)
6/8/2026
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Lower Price TargetOutperform$95.00 ➝ $92.00
6/5/2026
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Reiterated RatingSector Weight
6/5/2026
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Reiterated RatingSell$82.00 ➝ $66.00
(Data available from 7/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$4.09B3.35$6.03 per share11.64$41.44 per share1.69
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$13.18B0.73$7.76 per share10.90$33.12 per share2.55
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B9.89$14.93 per share36.13$20.10 per share26.83
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.52B2.88$5.88 per share12.44$26.72 per share2.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$374.90M$1.1859.5214.071.845.57%10.88%7.27%9/2/2026 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$398M$3.3125.5414.521.632.95%15.44%5.53%8/4/2026 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$13.5839.7232.632.9824.63%70.87%32.56%8/4/2026 (Confirmed)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$128.49M$2.3131.6518.562.279.03%13.54%7.94%7/30/2026 (Estimated)

Latest HSIC, COO, IDXX, and MMSI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.22N/AN/AN/A$3.37 billionN/A
8/4/2026Q2 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.95N/AN/AN/A$1.20 billionN/A
7/30/2026Q2 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.96N/AN/AN/A$405.25 millionN/A
6/4/2026Q2 2026
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$1.10$1.21+$0.11-$0.40$1.05 billion$1.08 billion
5/5/2026Q1 2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.20$1.32+$0.12$0.92$3.34 billion$3.37 billion
5/5/2026Q1 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.41$3.47+$0.06$3.47$1.12 billion$1.14 billion
4/30/2026Q1 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.84$0.94+$0.10$0.68$377.59 million$381.88 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
N/AN/A-100.00%N/AN/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
0.23
1.27
0.78
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.59
1.36
0.75
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.12
0.82
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.45
5.08
3.46

Institutional Ownership

CompanyInstitutional Ownership
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
24.39%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
2.08%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.89%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.79%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
15,000195.03 million190.97 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000113.92 million112.90 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.88 million78.26 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,50059.65 million59.24 millionOptionable

Recent News About These Companies

Zacks Research Analysts Reduce Earnings Estimates for MMSI
Zacks Research Has Pessimistic Outlook of MMSI Q3 Earnings
Merit Medical Systems : MMSI
Merit Medical (NASDAQ:MMSI) Sets Next Big Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cooper Companies stock logo

Cooper Companies NASDAQ:COO

$70.23 -0.27 (-0.38%)
Closing price 07/23/2026 04:00 PM Eastern
Extended Trading
$70.10 -0.13 (-0.18%)
As of 04:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$84.53 -0.28 (-0.33%)
Closing price 07/23/2026 04:00 PM Eastern
Extended Trading
$84.46 -0.07 (-0.08%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$539.36 -5.64 (-1.03%)
Closing price 07/23/2026 04:00 PM Eastern
Extended Trading
$540.50 +1.14 (+0.21%)
As of 07:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$73.11 0.00 (0.00%)
Closing price 07/23/2026 04:00 PM Eastern
Extended Trading
$71.97 -1.14 (-1.56%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.